Aurinia Pharmaceuticals Inc. (AUPH) stock
AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3062% below fair value
$15.73−0.48 (-2.96%)
Close on Nov 13, 2026Market cap $2.11BP/E 6.9Yield –
Aurinia Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Aurinia Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2026 was 97.7%. For fiscal 2025 it was 101.5%, against 2.4% the year before. The highest annual figure on record is 101.5% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 101.5% | +99.0 |
| FY2024 | Dec 31, 2024 | 2.4% | +46.9 |
| FY2023 | Dec 31, 2023 | -44.5% | +36.3 |
| FY2022 | Dec 31, 2022 | -80.7% | +316.1 |
| FY2021 | Dec 31, 2021 | -396.8% | −191.9 |
| FY2020 | Dec 31, 2020 | -204.9% | +27589.1 |
| FY2019 | Dec 31, 2019 | -27794.0% | −16329.9 |
| FY2018 | Dec 31, 2018 | -11464.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 37.9% | −5.1 |
| Q2 FY2026 | Jun 30, 2026 | 45.0% | +14.2 |
| Q1 FY2026 | Mar 31, 2026 | 44.2% | +6.8 |
| Q4 FY2025 | Dec 31, 2025 | 273.4% | +271.0 |
| Q3 FY2025 | Sep 30, 2025 | 42.9% | +21.8 |
| Q2 FY2025 | Jun 30, 2025 | 30.7% | +29.5 |
| Q1 FY2025 | Mar 31, 2025 | 37.4% | +58.7 |
| Q4 FY2024 | Dec 31, 2024 | 2.4% | +62.0 |
| Q3 FY2024 | Sep 30, 2024 | 21.2% | +45.8 |
| Q2 FY2024 | Jun 30, 2024 | 1.3% | +29.0 |
| Q1 FY2024 | Mar 31, 2024 | -21.4% | +54.8 |
| Q4 FY2023 | Dec 31, 2023 | -59.6% | +32.0 |
| Q3 FY2023 | Sep 30, 2023 | -24.7% | −8.6 |
| Q2 FY2023 | Jun 30, 2023 | -27.7% | +98.3 |
| Q1 FY2023 | Mar 31, 2023 | -76.2% | +97.9 |
| Q4 FY2022 | Dec 31, 2022 | -91.6% | +50.8 |
| Q3 FY2022 | Sep 30, 2022 | -16.1% | +326.5 |
| Q2 FY2022 | Jun 30, 2022 | -126.0% | +584.1 |
| Q1 FY2022 | Mar 31, 2022 | -174.0% | +5337.9 |
| Q4 FY2021 | Dec 31, 2021 | -142.4% | −126.2 |
| Q3 FY2021 | Sep 30, 2021 | -342.6% | +144933.2 |
| Q2 FY2021 | Jun 30, 2021 | -710.1% | +90820.9 |
| Q1 FY2021 | Mar 31, 2021 | -5511.9% | +80928.1 |
| Q4 FY2020 | Dec 31, 2020 | -16.1% | +118808.0 |
| Q3 FY2020 | Sep 30, 2020 | -145275.9% | −135078.5 |
| Q2 FY2020 | Jun 30, 2020 | -91531.0% | −35065.5 |
| Q1 FY2020 | Mar 31, 2020 | -86440.0% | −39450.0 |
| Q4 FY2019 | Dec 31, 2019 | -118824.1% | – |
| Q3 FY2019 | Sep 30, 2019 | -10197.4% | – |
| Q2 FY2019 | Jun 30, 2019 | -56465.5% | – |
| Q1 FY2019 | Mar 31, 2019 | -46990.0% | – |
See a number that looks wrong?